27 October 2022
Alpha Growth plc
("Alpha" or the "Company")
Appointment of Broker
Alpha Growth plc (LSE: ALGW and OTCQB: ALPGF), a leading financial services specialist in the growing longevity asset class, is pleased to announce the appointment of Allenby Capital Limited ("Allenby Capital") as the Company's sole Broker with effect from today.
Allenby Capital currently advises or is broker to over 70 corporate clients listed on AIM, the Standard List or AQUIS markets. Allenby Capital will provide Alpha Growth access to a broad spectrum of investors including institutional investors, family offices, private client brokers and high net worth individuals.
Gobind Sahney, Chairman, stated - "I am exceptionally pleased to announce the appointment of Allenby Capital as the Company's broker, I have been impressed by Allenby's approach to date and the speed at which they have understood the business, and look forward to working with them to introduce Alpha to a new cohort of retail and institutional investors."
For more information, please visit www.algwplc.com or contact the following:
| Alpha Growth Plc | +44 (0) 20 3959 8600 |
| Gobind Sahney, Executive Chairman | |
| Allenby Capital Limited | +44 (0) 20 3328 5656 |
| Amrit Nahal (Sales and Corporate Broking) | |
| Nick Athanas / Piers Shimwell (Corporate Finance) | |
| UK Investor Relations - Mark Treharne |
About Alpha Growth plc
Specialist in Longevity Assets
Alpha Growth plc is a financial advisory business providing specialist consultancy, advisory, and supplementary services to institutional and qualified investors globally in the multi-billion dollar market of life insurance linked longevity assets. Building on its well-established network, the Alpha Growth Group has a unique position in the longevity asset services and investment business, as a listed entity with global reach. The Group's strategy is to expand its advisory and business services via acquisitions and joint ventures in the UK and the US to attain commercial scale and provide holistic solutions to alternative institutional investors who are in need of specialised skills and unique access to deploy their financial resource in longevity assets.
Longevity Assets and Non-correlation
As a longevity asset, it is non-correlated to the real estate, equity capital and commodity markets. Its value is a function of time because as time passes the value gets closer to the face value of the policy. Hence creating a steady increase in the net asset value of the investment. This makes it highly attractive to investors wishing to counteract volatility within an investment portfolio and add yield.
Note: The Company only advises on and manages Longevity Assets that originate in the USA where the structured and life settlement market is highly regulated.
Important Notice
The content of this announcement has not been approved by an authorised person within the meaning of the Financial Services and Markets Act 2000 (FSMA). This announcement has been issued by and is the sole responsibility of the Company. The information in this announcement is subject to change.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
